Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 111-58-0
2. N-(2-hydroxyethyl)oleamide
3. Oleoyl Ethanolamide
4. (z)-n-(2-hydroxyethyl)octadec-9-enamide
5. Oleoyl Monoethanolamide
6. Oleic Monoethanolamide
7. N-(9z-octadecenoyl)-ethanolamine
8. N-(cis-9-octadecenoyl) Ethanolamine
9. 1hi5j9n8e6
10. 9-octadecenamide, N-(2-hydroxyethyl)-
11. Dtxsid1044516
12. 9-octadecenamide, N-(2-hydroxyethyl)-, (9z)-
13. Chebi:71466
14. Refchem:856533
15. Dtxcid9024516
16. 203-884-8
17. Oleoylethanolamine
18. N-oleoylethanolamine
19. Oleylethanolamide
20. Oleamide Mea
21. N-oleoyl Ethanolamine
22. N-oleoylethanolamide
23. N-oleoyl Ethanolamide
24. Mfcd00045972
25. N-(2-hydroxyethyl)-9-octadecenamide
26. (9z)-n-(2-hydroxyethyl)octadec-9-enamide
27. Oleic Acid Ethanolamide
28. N-(hydroxyethyl)oleamide
29. N-(hydroxyethyl) Oleamide
30. Oea
31. Chembl280065
32. N-?oleoylethanolamide
33. Sr-01000076041
34. Einecs 203-884-8
35. Unii-1hi5j9n8e6
36. Monoethanolamine Oleic Acid Amide
37. 9-octadecenamide, N-(2-hydroxyethyl)-, (z)-
38. 5ym
39. Olemsartan Medoximil
40. C18:1 Anandamide
41. Oleoyl 1-ethanolamide
42. Tocris-1484
43. N-oleoyl-2-aminoethanol
44. Oleoylethanolamide (oea)
45. Spectrum5_002037
46. Lopac-o-0383
47. Oleic Acid Monoethanolamide
48. Lopac0_000942
49. Mls002153155
50. Schembl177713
51. Gtpl2661
52. Orb1309303
53. Bdbm29080
54. N-(9z-octadecenoyl) Ethanolamine
55. Glxc-22224
56. Hms2233e21
57. Hms3262n06
58. Hms3412d21
59. Hms3649j05
60. Hms3676d21
61. Oleylethanolamide [who-dd]
62. Nae 18:1
63. Tox21_500942
64. Lmfa08040015
65. Msk159624
66. N-oleoylethanolamine, ~98% (tlc)
67. Nae(18:1)
68. Akos015839895
69. N-(2-hydroxyethyl)-9z-octadecenamide
70. Ccg-205023
71. Lp00942
72. Msk159624-100m
73. Sdccgsbi-0050916.p002
74. Msk159624-1000m
75. Ncgc00015761-01
76. Ncgc00015761-02
77. Ncgc00015761-03
78. Ncgc00015761-04
79. Ncgc00015761-05
80. Ncgc00015761-06
81. Ncgc00015761-07
82. Ncgc00015761-12
83. Ncgc00025182-01
84. Ncgc00025182-02
85. Ncgc00025182-04
86. Ncgc00025182-05
87. Ncgc00025182-06
88. Ncgc00261627-01
89. As-15152
90. Bp-43134
91. Fo180525
92. Smr001230650
93. Sy102076
94. Hy-107542
95. Cs-0028847
96. Eu-0100942
97. Ns00013916
98. O0345
99. C20792
100. D82195
101. O 0383
102. 111o580
103. 9-octadecenamide, N-(2-hydroxyethyl)-, Z
104. A802386
105. Q7086404
106. Sr-01000076041-1
107. Sr-01000076041-3
108. Sr-01000076041-8
109. Brd-k66956375-001-11-3
110. C18:1 Anandamide, 9z-octadecenoylethanolamide, Powder
111. N-oleoylethanolamine Solution In Methanol, 1000ug/ml
112. N-oleoylethanolamine Solution In Methanol, 100ug/ml
113. (z)-n-(2-hydroxyethyl)octadec-9-enamide;oleoylethanolamide
114. N-oleoylethanolamide; Oleamide Mea; Oleic Acid Monoethanolamide
115. N-oleoyl Ethanolamine, Oleoyl Monoethanolamide, Oleoylethanolamide
116. N-oleoylethanolamine; (9z)-n-(2-hydroxyethyl)-9-octadecenamide; Oleic Acid Ethanolamide
| Molecular Weight | 325.5 g/mol |
|---|---|
| Molecular Formula | C20H39NO2 |
| XLogP3 | 6.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 17 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 49.3 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 277 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Oleoylethanolamide (OEA) is a major N-acylethanolamine and an endogenous ethanolamide fatty acid. Although it is an endocannabinoids-like compound, it does not bind to cannabinoid receptors. Instead, this lipid sensor is an agonist at peroxisome proliferator-activated receptor- (PPAR-) agonist while also being an inhibitor of ceramidase and thereby the sphingolipid signaling pathway.
ABOUT THIS PAGE